Verastem
VSTM----
Verastem (VSTM)
Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States....
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Verastem Analyst Rating
View MoreForecast & Rating
Jul 17, 2026Price forecast
$15.00147.93%
Forecast & RatingStrong buy
9analysts
- Strong buy88.89%
- Buy11.11%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 1 day ago, 06:30 AM
Verastem Oncology to report Q2 2026 financial results in conference call
- benzinga_article · Jul 21 at 02:52 PM
These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why
- Global Report · Jul 14 at 06:47 AM
The Heterogeneity of Value Chains: From Synthetic Biology to Cloud Aggregators
- Global Report · Jul 8 at 10:32 PM
Under the Radar: The Tech, Biotech, and Defense Shifts You Missed
- StockTitan · Jul 2 at 07:30 AM
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | VSTM Stock News
- Tip Ranks · Jun 24 at 09:04 PM
Top Verastem Executives Quietly Cash Out in Fresh Stock Moves
